Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Lung Neoplasms × Tomography, Optical Coherence × Clear all

Status

Withdrawn 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Telangiectasis 1 Stomatitis 1 Rosacea 1 Port-Wine Stain 1 Neoplasms 1 Lung Neoplasms 1 Hemangioma 1 Head and Neck Neoplasms 1 Breast Neoplasms 1

Interventions

Carboplatin 38 Radiotherapy 29 Pemetrexed 27 Docetaxel 25 Cisplatin 25 Paclitaxel 20 Gemcitabine 17 Nivolumab 15 Radiosurgery 12 Etoposide 12 pembrolizumab 10 Erlotinib Hydrochloride 10 Magnetic Resonance Spectroscopy 9 Bevacizumab 8 Vinorelbine 7 Radiation 7 Cyclophosphamide 6 Immunoglobulin G 5 Gefitinib 5 Disulfides 5 Dexamethasone 5 Chemotherapy, Adjuvant 5 Celecoxib 5 durvalumab 4 bintrafusp alfa protein, human 4 atezolizumab 4 Specimen Handling 4 Irinotecan 4 Interviews as Topic 4 Fluorodeoxyglucose F18 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01039311 2013-02-01

OCT

University of Oklahoma

Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡